Deka Biosciences
Pre-clinicalRadically changing immunotherapy by developing precise treatments for inflammatory disease and cancer.
Founded
2020
Focus
Biologics
About
Radically changing immunotherapy by developing precise treatments for inflammatory disease and cancer.
Funding History
2Total raised: $55M
Series A$35MFrazier Healthcare PartnersSep 15, 2022
Seed$20MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2020
LocationGermantown, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile